A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a…
Read More »
A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a…
Read More »